Showing results (131-140 of 165) with videos related to
Sort By:
Pageof 17
European Urology|August 14, 2012
Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancerSean C Skeldon, Kara Semotiuk, Melyssa Aronson, et al.BJU International|December 18, 2023
Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancerChristian Vitug, Katherine Lajkosz, Julian Chavarriaga, et al.European Urology|September 10, 2014
Next-generation RNA sequencing of archival formalin-fixed paraffin-embedded urothelial bladder cancerYu Liu, Aidan P Noon, Eduardo Aguiar Cabeza, et al.Cancer Medicine|July 13, 2021
Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration-resistant prostate cancer treated with Radium-223Esmail M Al-Ezzi, Husam A Alqaisi, Marco A J Iafolla, et al.BJU International|November 13, 2010
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional studyCarmen Mir, Shahrokh F Shariat, Theodorus H van der Kwast, et al.International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate CancerRachel M Glicksman, Matthew Ramotar, Ur Metser, et al.BJU International|March 28, 2012
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancerBas W G van Rhijn, Liyang Liu, André N Vis, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2014
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classificationsBas W G van Rhijn, Mireia Musquera, Liyang Liu, et al.The Prostate|February 18, 2021
Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysisMarian S Wettstein, Luke A David, Clinsy Pazhepurackel, et al.BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.Pageof 17